NAD+ vs NADH : Guide d'identité, de mesure et de stabilité
The plus sign is not decorative: NAD+ is the oxidized form and NADH is the reduced form. Their formulas, spectra, redox behavior…
Lire la revue des sources →
Research Topic
Longévité et vieillissement cellulaire
Topic knowledge
Source-reviewed reading for longevity & cellular aging
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 7–10 of 10 reviewed articles · Page 2 of 2
Carte des preuves de l'homéostasie NAD+ : de la biologie cellulaire aux affirmations humaines
NAD+ is both a redox cofactor and a consumed substrate for signaling enzymes. That broad biology is well established, but it does…
Lire la revue des sources →SS-31, Elamipretide et Forzinity : pourquoi la distinction entre médicament fini est importante
SS-31 and elamipretide are names used around the same mitochondrial-targeted peptide, but Forzinity is a specific FDA-approved finished drug with an approved…
Lire la revue des sources →Elamiprétide dans le syndrome de Barth : ce que montrent l'essai sur les patients 12 et le dossier FDA
Elamipretide now has an FDA-approved finished product for a narrow Barth syndrome indication, but the approval rests on an unusual rare-disease dataset.…
Lire la revue des sources →Need a peptide for longevity & cellular aging research?
If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.